Genomic instability in precancerous lesions before inactivation of tumor suppressors p53 and APC in patients

Cell Cycle

Volumn 5, Issue 13, 2006, Pages 1443-1447

  Yang, Youxin ^a   Fruehauf, Johannes ^a   Xiang, Shuanglin ^a   Li, Chiang J ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

APC; Barrett's esophagus; Genomic instability; Multilayered epithelium; p53

Indexed keywords

APC PROTEIN; PROTEIN P53;

ARTICLE; BARRETT ESOPHAGUS; CARCINOGENESIS; CHROMOSOME 11; CHROMOSOME 12; CHROMOSOME 17; CHROMOSOME 18; CHROMOSOME 7; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DYSPLASIA; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGUS BIOPSY; ESOPHAGUS RESECTION; FLUORESCENCE IN SITU HYBRIDIZATION; GENOMIC INSTABILITY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LOWER ESOPHAGUS SPHINCTER; MOLECULAR PROBE; PRECANCER; PROTEIN EXPRESSION; TUMOR SUPPRESSOR GENE;

ANIMALIA;

EID: 33746590833     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.5.13.2897     Document Type: Article

References (25)

1. Rajagopalan H, Lengauer C. Aneuploidy and cancer. Nature 2004; 432:338-41.
2. Michor F, Iwasa Y, Vogelstein B, Lengauer C, Nowak MA. Can chromosomal instability initiate tumorigenesis? Semin Cancer Biol 2005; 15:43-9.
3. Shacter E, Weitzman SA. Chronic inflammation and cancer. Oncology (Williston Park) 2002; 16:217-26.
4. Shields HM, Zwas F, Antonioli DA, Doos WG, Kim S, Spechler SJ. Detection by scanning electron microscopy of a distinctive esophageal surface cell at the junction of squamous and Barrett's epithelium. Dig Dis Sci 1993; 38:97-108.
5. Boch JA, Shields HM, Antonioli DA, Zwas F, Sawhney RA, Trier JS. Distribution of cytokeratin markers in Barrett's specialized columnar epithelium. Gastroenterology 1997; 112:760-5.
6. Chen YY, Wang HH, Antonioli DA, Spechler SJ, Zeroogian JM, Goyal R, Shahsafaei A, Odze RD. Significance of acid-mucin-positive nongoblet columnar cells in the distal esophagus and gastroesophageal junction. Hum Pathol 1999; 30:1488-95.
7. Shields HM, Rosenberg SJ, Zwas FR, Ransil BJ, Lembo AJ, Odze R. Prospective evaluation of multilayered epithelium in Barrett's esophagus. Am J Gastroenterol 2001; 96:3268-73.
8. Glickman JN, Chen YY, Wang HH, Antonioli DA, Odze RD. Phenotypic characteristics of a distinctive multilayered epithelium suggests that it is a precursor in the development of Barrett's esophagus. Am J Surg Pathol 2001; 25:569-78.
9. Falk GW. Barrett's esophagus. Gastroenterology 2002; 122:1569-91.
10. Persons DL, Croughan WS, Borelli KA, Cherian R. Interphase cytogenetics of esophageal adenocarcinoma and precursor lesions. Cancer Genet Cytogenet 1998; 106:11-7.
11. Beuzen F, Dubois S, Flejou JF. Chromosomal numerical aberrations are frequent in oesophageal and gastric adenocarcinomas: A study using in-situ hybridization. Histopathology 2000; 37:241-9.
12. Sawhney RA, Shields HM, Allan CH, Boch JA, Trier JS, Antonioli DA. Morphological characterization of the squamocolumnar junction of the esophagus in patients with and without Barrett's epithelium. Dig Dis Sci 1996; 41:1088-98.
13. Reid BJ, Haggitt RC, Rubin CE, Roth G, Surawicz CM, Van Belle G, Lewin K, Weinstein WM, Antonioli DA, Goldman H, MacDonald W, Owen D. Observer variation in the diagnosis of dysplasia in Barrett's esophagus. Hum Pathol 1988; 19:166-78.
14. Yang Y, Jeanpierre C, Dressler GR, Lacoste M, Niaudet P, Gubler MC. WT1 and PAX-2 podocyte expression in Denys-Drash syndrome and isolated diffuse mesangial sclerosis. Am J Pathol 1999; 154:181-92.
15. Qian J, Bostwick DG, Takahashi S, Borell TJ, Brown JA, Lieber MM, Jenkins RB. Comparison of fluorescence in situ hybridization analysis of isolated nuclei and routine histological sections from paraffin-embedded prostatic adenocarcinoma specimens. Am J Pathol 1996; 149:1193-9.
16. Hopman AH, Voorter CE, Ramaekers FC. Detection of genomic changes in cancer by in situ hybridization. Mol Biol Rep 1994; 19:31-44.
17. Bektas N, Donner A, Wirtz C, Heep H, Gabbert HE, Sarbia M. Allelic loss involving the tumor suppressor genes APC and MCC and expression of the APC protein in the development of dysplasia and carcinoma in Barrett esophagus. Am J Clin Pathol 2000; 114:890-5.
18. Rosin MP, Anwar WA, Ward AJ. Inflammation, chromosomal instability, and cancer: The schistosomiasis model. Cancer Res 1994; 54:1929s-1933s.
19. Farhadi A, Fields J, Banan A, Keshavarzian A. Reactive oxygen species: Are they involved in the pathogenesis of GERD, Barrett's esophagus, and the latter's progression toward esophageal cancer? Am J Gastroenterol 2002; 97:22-6.
20. Hamelin R, Flejou JF, Muzeau F, Potet F, Laurent-Puig P, Fekete F, Thomas G. TP53 gene mutations and p53 protein immunoreactivity in malignant and premalignant Barrett's esophagus. Gastroenterology 1994; 107:1012-8.
21. Glickman JN, Yang A, Shahsafaei A, McKeon F, Odze RD. Expression of p53-related protein p63 in the gastrointestinal tract and in esophageal metaplastic and neoplastic disorders. Hum Pathol 2001; 32:1157-65.
22. Jones DR, Davidson AG, Summers CL, Murray GF, Quinlan DC. Potential application of p53 as an intermediate biomarker in Barrett's esophagus. Ann Thorac Surg 1994; 57:598-603.
23. Krishnadath KK, Tilanus HW, van Blankenstein M, Bosman FT, Mulder AH. Accumulation of p53 protein in normal, dysplastic, and neoplastic Barrett's oesophagus. J Pathol 1995; 175:175-80.
24. Novotna K, Trkova M, Pazdro A, Smejkal M, Soukupova A, Kodetova D, Smejkal P, Sedlacek Z. TP53 gene mutations are rare in nondysplastic Barrett's esophagus. Dig Dis Sci 2006; 51:110-3.
25. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990; 61:759-67.